Overview A Study of PTS for Patients With Solid Tumors Status: Withdrawn Trial end date: 2019-08-01 Target enrollment: Participant gender: Summary The primary objective of this study is to determine the MTD of PTS following local and intratumoral injections over a treatment course of two 5-day cycles to patients with palpable advanced solid malignancies who have failed standard treatment. Phase: Phase 1 Details Lead Sponsor: PTS International Inc.